Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Tuffin

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Thrombosis Research|January 15, 1986
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human plateletsP J Wade, D O Lunt, N Lad, et al.
British Journal of Pharmacology|February 1, 1989
Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivoR F Booth, A C Honey, N Lad, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human plateletsD P Tuffin, P Davey, R L Dyer, et al.
Biochemical Pharmacology|January 15, 1990
Ponalrestat: a potent and specific inhibitor of aldose reductaseW H Ward, C M Sennitt, H Ross, et al.
Thrombosis and Haemostasis|April 8, 1988
Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivoN Lad, A C Honey, D O Lunt, et al.
Biochemical Pharmacology|November 6, 1991
(2,6-Dimethylphenylsulphonyl)nitromethane: a new structural type of aldose reductase inhibitor which follows biphasic kinetics and uses an allosteric binding siteW H Ward, P N Cook, D J Mirrlees, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Inhibition of aldose reductase by (2,6-dimethylphenylsulphonyl)nitromethane: possible implications for the nature of an inhibitor binding site and a cause of biphasic kineticsW H Ward, P N Cook, D J Mirrlees, et al.
Journal of Medicinal Chemistry|October 1, 1987
Thromboxane synthase inhibitors. Synthesis and pharmacological activity of (R)-, (S)-, and (+/-)-2,2-dimethyl-6-[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)- methoxy]methyl]ethoxy]hexanoic acidsP W Manley, D P Tuffin, N M Allanson, et al.
Journal of Medicinal Chemistry|September 1, 1987
Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitorsP W Manley, N M Allanson, R F Booth, et al.
Biochemical Pharmacology|April 18, 1995
Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductaseP N Cook, W H Ward, J M Petrash, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Thrombosis Research|January 15, 1986
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human plateletsP J Wade, D O Lunt, N Lad, et al.
British Journal of Pharmacology|February 1, 1989
Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivoR F Booth, A C Honey, N Lad, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human plateletsD P Tuffin, P Davey, R L Dyer, et al.
Biochemical Pharmacology|January 15, 1990
Ponalrestat: a potent and specific inhibitor of aldose reductaseW H Ward, C M Sennitt, H Ross, et al.
Thrombosis and Haemostasis|April 8, 1988
Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivoN Lad, A C Honey, D O Lunt, et al.
Biochemical Pharmacology|November 6, 1991
(2,6-Dimethylphenylsulphonyl)nitromethane: a new structural type of aldose reductase inhibitor which follows biphasic kinetics and uses an allosteric binding siteW H Ward, P N Cook, D J Mirrlees, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Inhibition of aldose reductase by (2,6-dimethylphenylsulphonyl)nitromethane: possible implications for the nature of an inhibitor binding site and a cause of biphasic kineticsW H Ward, P N Cook, D J Mirrlees, et al.
Journal of Medicinal Chemistry|October 1, 1987
Thromboxane synthase inhibitors. Synthesis and pharmacological activity of (R)-, (S)-, and (+/-)-2,2-dimethyl-6-[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)- methoxy]methyl]ethoxy]hexanoic acidsP W Manley, D P Tuffin, N M Allanson, et al.
Journal of Medicinal Chemistry|September 1, 1987
Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitorsP W Manley, N M Allanson, R F Booth, et al.
Biochemical Pharmacology|April 18, 1995
Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductaseP N Cook, W H Ward, J M Petrash, et al.
Pageof 3